Circulating Tumor Cell Isolation: the Assets of Filtration Methods with Polycarbonate Track-etched Filters

Overview

Journal Chin J Cancer Res

Specialty Oncology

Date 2015 Nov 7

PMID 26543334

Citations 21

Authors

Claire Dolfus

Nicolas Piton

Emmanuel Toure

Jean-Christophe Sabourin

Affiliations

Soon will be listed here.

Abstract

Circulating tumor cells (CTCs) arise from primary or secondary tumors and enter the bloodstream by active or passive intravasation. Given the low number of CTCs, enrichment is necessary for detection. Filtration methods are based on selection of CTCs by size using a filter with 6.5 to 8 µm pores. After coloration, collected CTCs are evaluated according to morphological criteria. Immunophenotyping and fluorescence in situ hybridization techniques may be used. Selected CTCs can also be cultivated in vitro to provide more material. Analysis of genomic mutations is difficult because it requires adapted techniques due to limited DNA materials. Filtration-selected CTCs have shown prognostic value in many studies but multicentric validating trials are mandatory to strengthen this assessment. Other clinical applications are promising such as follow-up, therapy response prediction and diagnosis. Microfluidic emerging systems could optimize filtration-selected CTCs by increasing selection accuracy.

Citing Articles

Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).

Rusnakova D, Aziri R, Dubovan P, Jurik M, Mego M, Pindak D Oncol Lett. 2024; 29(1):10.

PMID: 39492933 PMC: 11526295. DOI: 10.3892/ol.2024.14756.

Simulating the Effect of Removing Circulating Tumor Cells (CTCs) from Blood Reveals That Only Implantable Devices Can Significantly Reduce Metastatic Burden of Patients.

Baumgartner W, Aceto N, Lifka S Cancers (Basel). 2024; 16(17).

PMID: 39272936 PMC: 11394430. DOI: 10.3390/cancers16173078.

Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications.

Salu P, Reindl K Cancers (Basel). 2024; 16(6).

PMID: 38539545 PMC: 10969710. DOI: 10.3390/cancers16061213.

Is cancer an intelligent species?.

Nicolazzo C, Francescangeli F, Magri V, Giuliani A, Zeuner A, Gazzaniga P Cancer Metastasis Rev. 2023; 42(4):1201-1218.

PMID: 37540301 PMC: 10713722. DOI: 10.1007/s10555-023-10123-0.

Modeling the Conductivity and Diffusion Permeability of a Track-Etched Membrane Taking into Account a Loose Layer.

Nichka V, Mareev S, Apel P, Sabbatovskiy K, Sobolev V, Nikonenko V Membranes (Basel). 2022; 12(12).

PMID: 36557191 PMC: 9786269. DOI: 10.3390/membranes12121283.

References

Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M . A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2011; 106(3):508-16. PMC: 3273340. DOI: 10.1038/bjc.2011.545. View

Krebs M, Hou J, Sloane R, Lancashire L, Priest L, Nonaka D . Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol. 2011; 7(2):306-15. DOI: 10.1097/JTO.0b013e31823c5c16. View

Chaffer C, Weinberg R . A perspective on cancer cell metastasis. Science. 2011; 331(6024):1559-64. DOI: 10.1126/science.1203543. View

Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N . Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014; 6(224):224ra24. PMC: 4017867. DOI: 10.1126/scitranslmed.3007094. View

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud J, Padovani B . "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One. 2014; 9(10):e111597. PMC: 4216113. DOI: 10.1371/journal.pone.0111597. View

Khoja L, Shenjere P, Hodgson C, Hodgetts J, Clack G, Hughes A . Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma. Melanoma Res. 2013; 24(1):40-6. DOI: 10.1097/CMR.0000000000000025. View

Chinen L, Machado de Carvalho F, Rocha B, Aguiar C, Abdallah E, Campanha D . Cytokeratin-based CTC counting unrelated to clinical follow up. J Thorac Dis. 2013; 5(5):593-9. PMC: 3815714. DOI: 10.3978/j.issn.2072-1439.2013.09.18. View

Iwanicki-Caron I, Basile P, Toure E, Antonietti M, Lecleire S, Di Fiore A . Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis. Am J Gastroenterol. 2013; 108(1):152-5. DOI: 10.1038/ajg.2012.367. View

Freidin M, Tay A, Freydina D, Chudasama D, Nicholson A, Rice A . An assessment of diagnostic performance of a filter-based antibody-independent peripheral blood circulating tumour cell capture paired with cytomorphologic criteria for the diagnosis of cancer. Lung Cancer. 2014; 85(2):182-5. DOI: 10.1016/j.lungcan.2014.05.017. View

10.

Bobek V, Gurlich R, Eliasova P, Kolostova K . Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. World J Gastroenterol. 2014; 20(45):17163-70. PMC: 4258587. DOI: 10.3748/wjg.v20.i45.17163. View

11.

Alix-Panabieres C, Pantel K . Circulating tumor cells: liquid biopsy of cancer. Clin Chem. 2012; 59(1):110-8. DOI: 10.1373/clinchem.2012.194258. View

12.

Bockhorn M, Jain R, Munn L . Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?. Lancet Oncol. 2007; 8(5):444-8. PMC: 2712886. DOI: 10.1016/S1470-2045(07)70140-7. View

13.

Wong N, Kahn H, Zhang L, Oldfield S, Yang L, Marks A . Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat. 2006; 99(1):63-9. DOI: 10.1007/s10549-006-9181-4. View

14.

Farace F, Massard C, Vimond N, Drusch F, Jacques N, Billiot F . A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer. 2011; 105(6):847-53. PMC: 3171010. DOI: 10.1038/bjc.2011.294. View

15.

Desitter I, Guerrouahen B, Benali-Furet N, Wechsler J, Janne P, Kuang Y . A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 2011; 31(2):427-41. View

16.

Sollier E, Go D, Che J, Gossett D, OByrne S, Weaver W . Size-selective collection of circulating tumor cells using Vortex technology. Lab Chip. 2013; 14(1):63-77. DOI: 10.1039/c3lc50689d. View

17.

Hofman V, Ilie M, Long-Mira E, Giacchero D, Butori C, Dadone B . Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients. J Invest Dermatol. 2013; 133(5):1378-81. DOI: 10.1038/jid.2012.485. View

18.

Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud J, Flejou J . Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology. 2011; 23(1):30-8. DOI: 10.1111/j.1365-2303.2010.00835.x. View

19.

Fiorelli A, Accardo M, Carelli E, Angioletti D, Santini M, Di Domenico M . Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis. Ann Thorac Surg. 2015; 99(6):1899-905. DOI: 10.1016/j.athoracsur.2014.11.049. View

20.

Hofman V, Ilie M, Long E, Selva E, Bonnetaud C, Molina T . Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method. Int J Cancer. 2010; 129(7):1651-60. DOI: 10.1002/ijc.25819. View